Stem Cell Cartilage Regeneration Market Analysis-2027



Global Stem Cell Cartilage Regeneration Market, by Stem Cell Type (Hematopoietic Stem Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), by Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, and Others), by End User (Hospitals & Clinics and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 298.3 million in 2019, and is expected to exhibit a CAGR of 9.1% over the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights

Stem cell-based therapy is a key focus in functional replacement of cartilage regeneration. Rising incidence of osteoarthritis among the global population is expected to increase adoption of efficient and promising treatment such as stem cell therapy during the forecast period. There were 14 million individuals in the U.S. who has symptomatic knee osteoarthritis and nearly 2 million people under the age of 45 that were suffering from symptomatic knee osteoarthritis as per Arthritis Foundation, 2017.

Furthermore, growing engagement of key players in developing stem cell therapy as commercially viable, safe, efficient, and economical therapeutic agents for cartilage regeneration is expected to drive growth of the global stem cell cartilage regeneration market over the forecast period. For instance, organizations such as California’s Stem Cell Agency is indulged in the development of new stem cell-based therapies for chronic diseases such as cancer and rare diseases. Moreover, manufacturers such as Sangamo Therapeutics and Fate Therapeutics are working on developing stem cell-based therapies for diseases such as β-Thalassemia and cancer, respectively.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report:

Furthermore, companies are also focusing on research and development activities, in order to launch novel products to increase their revenue in the stem cell cartilage regeneration market. According to Alliance for Regenerative Medicine, globally there were 946 clinical trials in progress in 2017, an 18% increase over the previous year.

Browse 32 Market Data Tables and 24 Figures spread through 154 Pages and in-depth TOC on “Global Stem Cell Cartilage Regeneration Market"

Rising mergers and acquisitions by major players to strengthen their share in this market is further expected to drive growth of stem cell cartilage regeneration market. For instance, in March 2015, Fujifilm Holding Corporation acquired Cellular Dynamics International, Inc. (CDI). CDI’s technology platform enables the production of high-quality fully functioning human cells, including induced pluripotent stem cells (iPSCs), on an industrial scale, which will help the Fujifilm Holding Corporation to strengthen their position in this segment.

Browse Research Report:

Key Takeaways of the Global Stem Cell Cartilage Regeneration Market:

The global stem cell cartilage regeneration market is expected to exhibit a CAGR of 9.1% over the forecast period (2019-2027), owing growing number of knee cartilage defects in patients with osteoarthritis (OA)

Among stem cell type, mesenchymal segment is expected to hold dominant position in the global stem cell cartilage regeneration market, owing to growing research and development activities pertaining to mesenchymal stem cells by various research organizations. For instance, in November 2018, a peer-reviewed case study conducted using a stem cell processed by Celltex Therapeutics Corporation, showed improvement in disease findings following systemic administration of autologous adipose derived mesenchymal stem cells.

Major players operating in the global stem cell cartilage regeneration market include Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation

Buy-Now this research report:

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:[email protected]

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737